Stocks VRNO Financial statements
Financial statementsVerano Holdings Corp. financial statements
Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Verano Holdings Corp. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Revenue | 229 | 738 | 879 | 938 | 879 | 822 |
| Cost of revenue | 93 | 407 | 456 | 463 | 435 | 408 |
| Gross profit | 136 | 331 | 423 | 475 | 444 | 413 |
| Selling, general and administrative | 43.3 | 271 | 357 | 332 | 353 | 337 |
| Operating expenses | 43.3 | 271 | 586 | 390 | 681 | 521 |
| Operating income | 95 | 64.7 | -161 | 84.8 | -237 | -107 |
| Other non-operating income | -12.5 | -15.7 | -2.27 | -57 | -62.7 | -59.1 |
| Pre-tax income | 82.5 | 49 | -163 | 27.8 | -300 | -166 |
| Income tax | 42.3 | 104 | 105 | 145 | 41.9 | 91.7 |
| Net income to minority interests | 1.76 | 2.51 | 0.29 | 0 | 0 | |
| Net income | 38.4 | -57.5 | -269 | -117 | -342 | -258 |
| EBITDA | 103 | 161 | -19.7 | 226 | -97.5 | 17.1 |
| EPS, basic | 0.15 | -0.20 | -0.81 | -0.34 | -0.98 | -0.71 |
| EPS, diluted | 0.14 | -0.20 | -0.81 | -0.34 | -0.98 | -0.71 |
| Shares, basic (weighted) | 264 | 290 | 331 | 343 | 350 | 361 |
| Shares, diluted (weighted) | 271 | 290 | 331 | 343 | 350 | 361 |
Balance sheet
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Cash and equivalents | 16.4 | 99.1 | 84.9 | 175 | 87.8 | 82.7 |
| Receivables | 17.4 | 16.6 | 39 | 40.3 | 30.9 | |
| Inventory | 141 | 165 | 156 | 184 | 230 | |
| Other current assets | 19.5 | 48.9 | 22.7 | 12.8 | 21.2 | |
| Total current assets | 277 | 318 | 394 | 363 | 405 | |
| Property, plant and equipment | 144 | 452 | 526 | 501 | 538 | 492 |
| Lease right-of-use assets | 61.3 | 82.3 | 93.5 | 99.9 | 93.8 | |
| Goodwill | 16 | 368 | 269 | 231 | 246 | 161 |
| Intangible assets | 72.4 | 1,380 | 1,181 | 1,086 | 734 | 579 |
| Total assets | 2,549 | 2,396 | 2,319 | 1,994 | 1,742 | |
| Accounts payable | 45.2 | 40.5 | 31.3 | 39.9 | 38.7 | |
| Accrued liabilities | 42.1 | 41.8 | 66.8 | 68.9 | 69.3 | |
| Deferred revenue | 2.62 | 3.58 | 5.78 | 7.45 | 7.51 | |
| Short-term debt | 13.8 | 24.5 | 52 | 18.2 | 7.85 | |
| Total current liabilities | 471 | 387 | 412 | 203 | 140 | |
| Long-term debt | 276 | 389 | 394 | 396 | 392 | |
| Lease liabilities | 56.8 | 76.9 | 87.4 | 97.9 | 91.1 | |
| Other non-current liabilities | 0 | 5.99 | 0.26 | 1.91 | 1.08 | |
| Total liabilities | 1,067 | 1,055 | 1,079 | 1,043 | 1,039 | |
| Total debt | 290 | 413 | 446 | 414 | 400 | |
| Paid-in capital | 1,736 | 1,746 | ||||
| Retained earnings | -784 | -1,042 | ||||
| Treasury stock | 0 | |||||
| Other comprehensive income | 0.01 | 0 | ||||
| Shareholders' equity | 1,481 | 1,342 | 1,240 | 952 | 704 | |
| Minority interests | 1.28 | 0 | 0 | -1.36 | -1.78 | |
| Total equity | 1,482 | 1,342 | 1,240 | 951 | 702 | |
| Total liabilities and equity | 2,549 | 2,396 | 2,319 | 1,994 | 1,742 | |
| Shares outstanding | 72.6 |
Cash flow statement
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Net income | 40.2 | -55 | -269 | -117 | -342 | -258 |
| Depreciation and amortization | 7.87 | 96.2 | 141 | 141 | 140 | 124 |
| Stock-based compensation | 0 | 45.3 | 39.1 | 13.2 | 16.9 | 11.5 |
| Deferred income tax | 1.54 | -33.1 | -62.1 | -14.3 | -109 | -37.5 |
| Change in receivables | -2.51 | -6.67 | 0.82 | -22.7 | -2.75 | 5.36 |
| Change in inventory | -22.9 | -59.5 | -24.2 | 23.9 | -15.9 | -46.8 |
| Change in payables | 1.78 | 9.92 | -7.58 | -8.88 | -4.18 | 5.37 |
| Cash from operations | 71.6 | 183 | 94.3 | 110 | 112 | 52.9 |
| Capital expenditures | -60.2 | -141 | -119 | -36.3 | -99 | -41.2 |
| Acquisitions | -21.9 | -310 | -115 | 0 | -35.9 | 0 |
| Cash from investing | -86.9 | -456 | -208 | -34.2 | -133 | -32.6 |
| Debt issued | 33.9 | 225 | 497 | 79.1 | 0 | 62 |
| Debt repaid | -9.75 | -10.8 | -374 | -49.9 | -63.4 | -77.9 |
| Dividends paid | -0.05 | 0 | 0 | |||
| Cash from financing | 25.3 | 356 | 99.2 | 14.4 | -65.9 | -25.3 |
| Exchange rate effect | 0 | -0.01 | -0.01 | 0.02 | -0.01 | |
| Net change in cash | 9.99 | 82.7 | -14.3 | 89.9 | -87 | -5.07 |
| Free cash flow | 11.5 | 41.6 | -24.8 | 73.4 | 13.1 | 11.6 |
| Interest paid | 1.76 | 18.7 | 48.2 | 59.2 | 52.6 | 48.2 |
| Income taxes paid | 10.2 | 28 | 70.7 | 167 | 81.5 | 78.2 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 47.8% | Gross profit / revenue. |
| Operating margin | -15.8% | Operating income / revenue. |
| EBITDA margin | -1.5% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -24.5% | Pre-tax income / revenue. |
| Net margin | -30.9% | Net income / revenue. |
| FCF margin | 5.5% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 10.7% | Cash from operations / revenue. |
| Return on equity (ROE) | -38.2% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -15.2% | Net income / average total assets. |
| Return on invested capital (ROIC) | -10.6% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| SG&A / revenue | 41.3% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 1.5% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 5.2% | Capital expenditures / revenue. |
| D&A / revenue | 14.3% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -6.5% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -2.2% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 29.2% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -6.9% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -0.8% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 25.0% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | -30.2% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -52.9% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | -17.6% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | -5.9% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -11.5% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 5y | 0.3% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | -26.0% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | -19.3% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | -12.7% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -10.1% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Share count change, 1y | 3.2% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 2.9% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 5.9% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 3.70x | Current assets / current liabilities. |
| Quick ratio | 1.04x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.78x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.58x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 23.1% | Total debt / total assets. |
| Liabilities / assets | 60.3% | Total liabilities / total assets. |
| Net debt | $307.4M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Working capital | $294.9M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 41.8% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | -$34.6M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.49x | Revenue / average total assets. |
| Fixed asset turnover | 1.72x | Revenue / average property, plant and equipment. |
| Inventory turnover | 1.96x | Cost of revenue / average inventory. |
| Days inventory | 186 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 29.0x | Revenue / average receivables. |
| Days sales outstanding | 13 days | 365 x average receivables / revenue. |
| Days payables | 22 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 176 days | Days inventory + days sales outstanding - days payables. |
| Capex / operating cash flow | 48.9% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$3.54 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $11.44 | Revenue / diluted weighted shares. |
| FCF per share | $0.63 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $1.22 | Cash from operations / diluted weighted shares. |
| Book value per share | $9.24 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | -$0.47 | Tangible book value / shares outstanding. |
| Cash per share | $1.16 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $438.6M | Share price x shares outstanding. |
| Enterprise value | $746.0M | Market cap + total debt - cash - short-term investments. |
| P/S | 0.52x | Market cap / revenue. |
| P/B | 0.65x | Market cap / shareholders' equity. Only when equity is positive. |
| P/FCF | 9.60x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 4.91x | Market cap / cash from operations, when positive. |
| EV/Sales | 0.89x | Enterprise value / revenue. |
| EV/FCF | 16.3x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 10.4% | Free cash flow / market cap. |
| Earnings yield | -58.9% | Net income / market cap (the inverse of P/E). |
What was Verano Holdings Corp.'s revenue in fiscal 2025?
Verano Holdings Corp. reported revenue of $821.5M for fiscal 2025, 6.5% lower than the year before.
Was Verano Holdings Corp. profitable in fiscal 2025?
No. It reported a net loss of $257.9M.
How much free cash flow did Verano Holdings Corp. generate in fiscal 2025?
Cash from operations of $52.9M minus capital expenditures of $41.2M left free cash flow of $11.6M.